ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,578Medicare Part D Prescriptions Filled, Including Refills

Rank: 373 out of 2094

$783K Total Retail Price of All Prescriptions

Rank: 187 out of 2094

569 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 569 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

4% of this provider’s 569 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 6,109 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$103 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 342 280 1 1
LEVOTHYROXINE SODIUM 233 186 2 3
SYNTHROID 201 164 3 44
FUROSEMIDE 198 172 4 6
METFORMIN HCL 197 162 5 8
AMLODIPINE BESYLATE 191 172 6 2
LISINOPRIL 190 161 7 7
METOPROLOL TARTRATE 186 181 8 10
OMEPRAZOLE 168 118 9 4
HYDROCHLOROTHIAZIDE 167 150 10 12
ATORVASTATIN CALCIUM 155 129 11 5
WARFARIN SODIUM 150 108 12 11
ZOLPIDEM TARTRATE 109 85 13 14
CRESTOR 98 81 14 15
CARVEDILOL 98 88 14 19
AZITHROMYCIN 93 71 16 27
BYSTOLIC 90 88 17 83
DIOVAN 89 76 18 13
PREDNISONE 89 74 18 54
JANUVIA 80 60 20 35
CIPROFLOXACIN HCL 79 64 21 81
TAMSULOSIN HCL 74 63 22 29
NEXIUM 70 46 23 16
RAMIPRIL 68 57 24 48
LOSARTAN POTASSIUM 68 65 24 17
SYMBICORT 63 51 26 149
METOPROLOL SUCCINATE 60 57 27 9
ATENOLOL 59 55 28 21
CLOPIDOGREL 58 49 29 22
TRILIPIX 56 51 30 156
DIOVAN HCT 52 42 31 28
IBUPROFEN 52 14 31 73
LANTUS SOLOSTAR 51 32 33 76
GLIPIZIDE 51 47 33 82
ROPINIROLE HCL 51 46 33 235
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 31, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.